Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

CUE 102

Next Previous
Drug Profile

CUE 102

Alternative Names: CUE-102; CUE-A02

Latest Information Update: 24 Apr 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cue Biopharma
  • Class Antineoplastics; Immunotherapies; Interleukins; Recombinant fusion proteins
  • Mechanism of Action Interleukin 2 replacements; T lymphocyte stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Cancer

Highest Development Phases

  • Phase I Cancer

Most Recent Events

  • 24 Apr 2025 CUE 102 is available for licensing as of 31 Dec 2024. https://www.cuebiopharma.com/
  • 09 Apr 2025 Cue Biopharma plans a phase Ib trial for Glioblastoma (Second-line therapy or greater) in The US in September 2025 (IV) (NCT06917885)
  • 12 Mar 2025 Cue Biopharma completes phase I trial in Cancer (Metastatic disease, Monotherapy, Recurrent, Second-line therapy or greater) in USA (IV) (NCT05360680)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top